MNK-155 Human Abuse Liability (HAL) Study

Trial Profile

MNK-155 Human Abuse Liability (HAL) Study

Phase of Trial: Phase I

Latest Information Update: 11 Sep 2014

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Pain
  • Focus Pharmacodynamics
  • Sponsors Mallinckrodt Inc.
  • Most Recent Events

    • 11 Sep 2014 New trial record
    • 03 Sep 2014 Primary endpoint has been met. (Abuse liability)
    • 03 Sep 2014 Results published in the Media Release and presented at PAINWeek 2014.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top